Back to search

Article

Bioinformatics-based analysis of TCGA to identify the prognostic biomarkers in HR-positive/HER2-negative tamoxifen-treated breast cancer

2019-09-12

Abstract excerpt

<title>Abstract</title> <p>Background Patients with hormone receptor-positive (HR+) breast cancer, which accounts for approximately 70% of all breast cancers, receive tamoxifen therapy to inhibit recurrence and improve overall survival. However, the cumulative risk of distant recurrence in the past 20 years is still as high as 22 to 52% after 5 years of endotherapy. TNM stage, histological grade and age are impor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c95b3c63-2ae1-50a3-9dc8-b39f804105b4
DOI
10.21203/rs.2.14316/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bioinformatics-based analysis of TCGA to identify the prognostic biomarkers in HR-positive/HER2-negative tamoxifen-treated breast cancerDOI 10.21203/rs.2.14316/v1
Select a neighboring publication to make it the new centre.